189
Participants
Start Date
June 1, 2023
Primary Completion Date
December 25, 2025
Study Completion Date
December 25, 2025
Tizanidine Hydrochloride
Tizanidine Hydrochloride 1 mg Tid for 12 consecutive weeks and were followed up for 12 weeks
Tizanidine Hydrochloride
Tizanidine Hydrochloride 2 mg Tid for 12 consecutive weeks and were followed up for 12 weeks
Tizanidine Hydrochloride Placebo
Tizanidine Hydrochloride Placebo Comparator 1 tablet Tid for 12 consecutive weeks and were followed up for 12 weeks
NOT_YET_RECRUITING
The Affiliated Hospital of Southwest Medical University, Luzhou
RECRUITING
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
RECRUITING
The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
NOT_YET_RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
RECRUITING
The First Hospital of Jiaxing, Jiaxing
ACTIVE_NOT_RECRUITING
Affiliated Hospital of Shaoxing University, Shaoxing
Sichuan Credit Pharmaceutical Co., Ltd.
INDUSTRY
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER